The results indicated that high expression levels of OPN4, NOS2, GPR157, NCOA2, CLOCK, and TH were associated with shorter OS in breast cancer patients, while high expression of EGR3, NR1H3, RELB, SIAH2, and ADRB1 was linked to improved survival rates (Figure 6). Here, NOS2 is linked to breast carcinoma.